Immunogenicity, safety and tolerability of intradermal influenza vaccines

References

• World Health Organization. Media centre. Influenza (Seasonal). Fact sheet, November, 2016. Available at: http://www.who.int/mediacentre/factsheets/fs211/en/ (accessed June 17, 2017)
   Google Scholar
• Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357:1373-81; PMID:17914038; https://doi.org/10.1056/NEJMoa070844
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518-27; PMID:7661497; https://doi.org/10.7326/0003-4819-123-7-199510010-00008
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Durando P, Icardi G. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin Bio Ther 2011; 11:415-27; https://doi.org/10.1517/14712598.2011.557658
   PubMed Web of Science ®Google Scholar
• Young F, Marra F. A systematic review of intradermal influenza vaccines. Vaccine 2011; 29:8788-801; PMID:21968444; https://doi.org/10.1016/j.vaccine.2011.09.077
   PubMed Web of Science ®Google Scholar
• Marra F, Young F, Richardson K, Marra CA. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events. Influenza Other Respir Viruses 2013; 7:584-603; PMID:22974174; https://doi.org/10.1111/irv.12000
   PubMed Web of Science ®Google Scholar
• Camilloni B, Basileo M, Valented S, Nunzi E, Iorio AM. Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review. Hum Vaccin Immunother 2015; 11:553-63; PMID:25714138; https://doi.org/10.1080/21645515.2015.1011562
   PubMed Web of Science ®Google Scholar
• Pileggi C, Mascaro V, Bianco A, Nobile CG, Pavia M. Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-analysis of randomized controlled trials. Drugs Aging 2015; 32:857-69; PMID:26442860; https://doi.org/10.1007/s40266-015-0303-8
   PubMed Web of Science ®Google Scholar
• Pileggi C, Lotito F, Bianco A, Nobile CG, Pavia M. Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials. BMC Infect Dis 2015; 15:427; PMID:26466898; https://doi.org/10.1186/s12879-015-1161-z
   PubMed Web of Science ®Google Scholar
• Gross CP, Sepkowitz KA. The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered. IJID 1998; 3:54-60; PMID:9831677
   PubMedGoogle Scholar
• Calmette A. Preventive vaccination against tuberculosis with BCG. Proc R Soc Med 1931; 24:1481; PMID:19988326
   PubMedGoogle Scholar
• Rubin BA. A note on the development of the bifurcated needle for smallpox vaccination. WHO Chron 1980; 34:180-1; PMID:7376638
   PubMedGoogle Scholar
• Baxby D. Smallpox vaccination techniques; from knives and forks to needles and pins. Vaccine 2002; 20:2140-9; PMID:11972983; https://doi.org/10.1016/S0264-410X(02)00028-2
   PubMed Web of Science ®Google Scholar
• Salisbury DM, Begg NT. Tuberculosis: BCG immunization. In: Immunization against infectious disease. London: HMSO, 1996:219-41. Available at: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_113539.pdf (accessed June 17, 2017)
   Google Scholar
• FrÖsner G, Steffen R, Herzog C. Virosomal hepatitis A vaccine: comparing intradermal and subcutaneous with intramuscular administration. J Travel Med 2009; 16:413-9; PMID:19930383; https://doi.org/10.1111/j.1708-8305.2009.00351.x
   PubMed Web of Science ®Google Scholar
• Sangare L, Manhart L, Zehrung D, Wang CC. Intradermal hepatitis B vaccination: a systematic review and meta-analysis. Vaccine 2009; 27:1777-86; PMID:19200451; https://doi.org/10.1016/j.vaccine.2009.01.043
   PubMed Web of Science ®Google Scholar
• Braddick MR. Intradermal hepatitis B vaccine. Lancet 1989; 1:957-8; https://doi.org/10.1016/S0140-6736(89)92533-6
   PubMed Web of Science ®Google Scholar
• Fishbein DB, Pacer RE, Holmes DF, Ley AB, Yager P, Tong TC. Rabies pre exposure prophylaxis with human diploid cell rabies vaccine: a dose–response study. J Infect Dis 1987; 156:50-5; PMID:3598225; https://doi.org/10.1093/infdis/156.1.50
   PubMed Web of Science ®Google Scholar
• Zoulek G, Roggendorf M, Deinhardt F, Kunz C. Different immune responses after intradermal and intramuscular administration of vaccine against tick borne encephalitis virus. J Medical Virol 1986; 19:55-61; PMID:3701303; https://doi.org/10.1002/jmv.1890190109
   PubMed Web of Science ®Google Scholar
• Whittle HC, Rowland MG, Mann GF, Lamb WH, Lewis RA. Immunisation of 4–6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet 1984; 2:834-7; https://doi.org/10.1016/S0140-6736(84)90873-0
   PubMed Web of Science ®Google Scholar
• Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MM, Sharif SM, van der Avoort HG, Pallansch MA, Malankar P, et al. Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med 2010; 362:2351-9; PMID:20573923; https://doi.org/10.1056/NEJMoa0909383
   PubMed Web of Science ®Google Scholar
• Francis T, Magill T. The antibody response of human subjects vaccinated with the virus of human influenza. J Exp Med 1937; 65:251; PMID:19870599; https://doi.org/10.1084/jem.65.2.251
   PubMedGoogle Scholar
• Van Gelder D, Greenspan F, Dufresne N. Influenza vaccination: comparison of intracutaneous and subcutaneous methods. Naval Med Bulletin 1947; 47:197
   PubMedGoogle Scholar
• Bruyn H, Meikeljohn G, Brainerd H. Influenza vaccination: A comparison of antibody response obtained by various methods of administration. J Immunol 1949; 62:1; PMID:18131592
   PubMed Web of Science ®Google Scholar
• Bruyn H, Meikeljohn G, Brainerd H. Influenza vaccine. Amer J Dis Child 1949; 77:149; https://doi.org/10.1001/archpedi.1949.02030040158001
   PubMedGoogle Scholar
• Hilleman M, Flatley F, Anderson S, Luecking ML, Levinson DJ. Antibody response in volunteers to Asian influenza vaccine. JAMA 1958; 166:1134; https://doi.org/10.1001/jama.1958.02990100022005
   PubMed Web of Science ®Google Scholar
• Sanger M. Immunization after intradermal and subcutaneous injection of Asian influenza vaccine. Ann Allergy 1959; 17:173; PMID:13650417
   PubMedGoogle Scholar
• Beasley AR, Sigel MM, Schlaepfer GG, Edwards HK, Mangels M Jr, Wellings FM. Antibody responses of children to Asian influenza vaccine. J Fla Med Assoc 1960; 46:1367-71
   Google Scholar
• Kirkham L. Asiatic influenza in a midwestern town. J Iowa Med Soc 1958; 45:593
   Google Scholar
• Philips C, Forsyth, B, Christmas W, Gump DW, Whorton EB, Rogers I, Rudin A. Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization. J Infect Dis 1970; 122:26; PMID:5433710; https://doi.org/10.1093/infdis/122.1-2.26
   PubMed Web of Science ®Google Scholar
• Marks M, Eller J. Intradermal influenza immunization. Am Rev Respir Dis 1971; 103:579; PMID:5550353
   PubMed Web of Science ®Google Scholar
• Halperin W, Weiss WI, Altman R, Diamond MA, Black KJ, Iaci AW, Black HC, Goldfield M. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature. Am J Public Health 1979; 1247-50; PMID:507256; https://doi.org/10.2105/AJPH.69.12.1247
   PubMed Web of Science ®Google Scholar
• Appleby JC, Himmelweit F, Stuart-Harris CH. Immunization with influenza virus A vaccines. Comparison of intradermal and subcutaneous routes. Lancet 1951; 1:1384-7; PMID:14842090; https://doi.org/10.1016/S0140-6736(51)92840-1
   PubMedGoogle Scholar
• Boger W, Liu O. Subcutaneous and intradermal vaccination with Asian vaccine. JAMA 1975; 165:1687; https://doi.org/10.1001/jama.1957.72980310001010
   Google Scholar
• Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004; 351:2286-94; PMID:15525713; https://doi.org/10.1056/NEJMoa043555
   PubMed Web of Science ®Google Scholar
• Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004; 351:2295-301; PMID:15525714; https://doi.org/10.1056/NEJMoa043540
   PubMed Web of Science ®Google Scholar
• Altmar RL, Patel SM, Keitel WA. Intanza(®): a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines 2010; 9:1399-40; PMID:21105776; https://doi.org/10.1586/erv.10.134
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Durando P, Icardi G. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin Bio Ther 2011; 11:415-27; https://doi.org/10.1517/14712598.2011.557658
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Canepa P, Ceravolo A, Valle L, de Florentiis D, Oomen R, Vogel FR, Denis M, Samson SI, Icardi G. Intanza(®) 15 mg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses. Vaccine 2012; 30:2908-13; PMID:22342501; https://doi.org/10.1016/j.vaccine.2012.02.003
   PubMed Web of Science ®Google Scholar
• Hung IF, Levin Y, To KK, Chan KH, Zhang AJ, Li P, Li C, Xu T, Wong TY, Yuen KY. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine 2012; 30:6427-35; PMID:22910287; https://doi.org/10.1016/j.vaccine.2012.08.014
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Orsi A, de Florentilis D, Parodi V, Rappazzo E, Coppelli M, Durando P, Icardi G. Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability. Hum Vaccin Immunother 2013; 9:591-8; https://doi.org/10.4161/hv.23240
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Weber F. Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccin Immunother 2013; 9:115-21; PMID:23442585; https://doi.org/10.4161/hv.22342
   PubMed Web of Science ®Google Scholar
• Hoon Han S, Hee Woo J, Weber F, Joo Kim W, Ran Peck K, Il Kim S, Hwa Choi Y, Myung Kim J. Immunogenicity and safety of Intanza(®)/IDflu(®) intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial. Hum Vaccin Immunother 2013; 9:1971-7; PMID:23778938; https://doi.org/10.4161/hv.25295
   PubMed Web of Science ®Google Scholar
• Camilloni B, Basileo M, Di Martino A, Donatelli I, Iorio AM. Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains. Immun Ageing 2014; 11:10; PMID:24860610; https://doi.org/10.1186/1742-4933-11-10
   PubMed Web of Science ®Google Scholar
• Chan TC, Hung IF, Chan KH, Li CP, Li PT, Luk JK, Chu LW, Chan FH. Immunogenicity and safety of intradermal trivalent influenza vaccination in nursing home older adults: a randomized controlled trial. J Am Med Dir Assoc 2014; 15:60; https://doi.org/10.1016/j.jamda.2014.07.014
   Web of Science ®Google Scholar
• Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM. Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review. Hum Vaccin Immunother 2015; 11:553-63; PMID:25714138; https://doi.org/10.1080/21645515.2015.1011562
   PubMed Web of Science ®Google Scholar
• Arnou R, Frank M, Hagel T, Prébet A. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther 2011; 28:555-65; PMID:21626269; https://doi.org/10.1007/s12325-011-0035-z
   PubMed Web of Science ®Google Scholar
• Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther 2011; 28:640-9; PMID:21751080; https://doi.org/10.1007/s12325-011-0042-0
   PubMed Web of Science ®Google Scholar
• Prymula R, Usluer G, Altinel S, Sichova R, Weber F. Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey. Adv Ther 2012; 29:41-52
   PubMed Web of Science ®Google Scholar
• Dhont PA, Albert A, Brenders P, Podwapinska A, Pollet A, Scheveneels D, Tihon F, Verheyden I, Victor J, Samson SI. Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010-2011 influenza season. Adv Ther 2012; 29:562-77; PMID:22678831; https://doi.org/10.1007/s12325-012-0025-9
   PubMed Web of Science ®Google Scholar
• Coleman BL, McNeil SA, Langley JM, Halperin SA, McGeer AJ. Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers. Vaccine 2015; 33:6635-40; PMID:26529074; https://doi.org/10.1016/j.vaccine.2015.10.095
   PubMed Web of Science ®Google Scholar
• Gardeniers HJ, Luttge R, Berenschot EJ, de Boer MJ, Yeshurun SY, Hefetz M, van't Oever R, van den Berg A. Silicon micromachined hollow microneedles for transdermal liquid transport. J Microelectromech Syst 2003; 12:855-62; https://doi.org/10.1109/JMEMS.2003.820293
   Google Scholar
• Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intra-dermal influenza vaccination in healthy adults. Vaccine 2009; 27:454-9; PMID:19022318; https://doi.org/10.1016/j.vaccine.2008.10.077
   PubMed Web of Science ®Google Scholar
• Hung IF, Levin Y, To KK. Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination. Vaccine 2012; 30:2707-8; https://doi.org/10.1016/j.vaccine.2011.12.069
   PubMed Web of Science ®Google Scholar
• Della Cioppa G, Nicolay U, Lindert K, Leroux-Roels G, Clement F, Castellino F, Galli C, Groth N, Levin Y, Del Giudice G. A dose-range study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration. Hum Vaccines Immunotherapeutics 2014; 10(6):1701-10; https://doi.org/10.4161/hv.28618
   PubMed Web of Science ®Google Scholar
• Levin Y, Kochba E, Shukarev G, Rusch S, Herrera-Taracena G, van Damme P. A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly. Vaccine 2016; 34:5262-72; PMID:27667332; https://doi.org/10.1016/j.vaccine.2016.09.008
   PubMed Web of Science ®Google Scholar
• Levin Y, Kochba E, Hung I, Kenney R. Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future. Hum Vaccin Immunother 2015; 11:991-7; PMID:25745830; https://doi.org/10.1080/21645515.2015.1010871
   PubMed Web of Science ®Google Scholar
• Chen XZ, Mao XH, Zhu KJ, Jin N, Ye J, Cen JP, Zhou Q, Cheng H. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells. Arch Dermatol Res 2010; 302:57-65; PMID:19578865; https://doi.org/10.1007/s00403-009-0976-0
   PubMed Web of Science ®Google Scholar
• Zhang AJ, Li C, To KK, Zhu HS, Lee AC, Li CG, Chan JF, Hung IF, Yuen KY. TLR7 agonist imiquimod in combination with influenza vaccine expedite and augment humoral immune responses against influenza A(H1N1)pdm09 infection in BALB/c mice. Clin Vaccine Immunol 2014; 21:570-9; PMID:24521786; https://doi.org/10.1128/CVI.00816-13
   PubMed Web of Science ®Google Scholar
• Hung IF, Zhang AJ, To KK, Chan JF, Li C, Zhu HS, Li P, Li C, Chan TC, Cheng VC, et al. Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial. Clin Infect Dis 2014; 59:1246-55; PMID:25048848; https://doi.org/10.1093/cid/ciu582
   PubMed Web of Science ®Google Scholar
• Hung IF, Zhang AJ, To KK, Chan JF, Li P, Wong TL, Zhang R, Chan TC, Chan BC, Wai HH, et al. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial. Lancet Infect Dis 2016; 16:209-18; PMID:26559482; https://doi.org/10.1016/S1473-3099(15)00354-0
   PubMed Web of Science ®Google Scholar
• Bragazzi NL, Orsi A, Ansaldi F, Gasparini R, Icardi G. Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview. Hum Vaccin Immunother 2016; 12:2616-27; PMID:27246556; https://doi.org/10.1080/21645515.2016.1187343
   PubMed Web of Science ®Google Scholar